Ven­tureWise splits with MedRe­leaf

Pharmacy Daily - - News -

NPS MedicineWise off­shoot Ven­tureWise has for­mally an­nounced the dis­con­tin­u­a­tion of its part­ner­ship with medic­i­nal cannabis com­pany MedRe­leaf

(PD 06 Feb), which in­cluded the devel­op­ment of ed­u­ca­tional re­sources on medic­i­nal cannabis for phar­ma­cists, GPs and spe­cial­ists.

Ven­tureWise man­ag­ing di­rec­tor Greg Hughes is­sued a state­ment on Fri af­ter­noon, con­firm­ing that his or­gan­i­sa­tion had been en­gaged by MedRe­leaf “to de­velop in­de­pen­dent in­for­ma­tion for health­care pro­fes­sion­als to im­prove pre­scriber knowl­edge about medic­i­nal cannabis and the reg­u­la­tory frame­work”.

Hughes said the pro­ject aligned with the NPS MedicineWise group’s over­ar­ch­ing mis­sion of im­prov­ing the qual­ity use of medicines in Aus­tralia.

How­ever “un­for­tu­nately the scope of the pro­ject was pre­sented by MedRe­leaf be­yond what we orig­i­nally agreed, and as a re­sult our part­ner­ship will cease ef­fec­tive im­me­di­ately,” Hughes said.

“We wish MedRe­leaf all the best with their future en­deav­ours.”

MedRe­leaf Aus­tralia is headed up by phar­ma­cist Rus­sell Harding, who has es­tab­lished a joint ven­ture with Canada’s Medre­leaf Corp, an ISO 9001 and GMP cer­ti­fied pro­ducer of medic­i­nal cannabis.

MedRe­leaf plans to spon­sor uni­ver­si­ties in Qld and South Aus­tralia to per­form a se­ries of tri­als in­volv­ing the firm’s prod­ucts across sev­eral dis­ease states.

Newspapers in English

Newspapers from Australia

© PressReader. All rights reserved.